Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03336333
Title A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL (SEQUOIA)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors BeiGene

chronic lymphocytic leukemia

chronic lymphocytic leukemia/small lymphocytic lymphoma


Venetoclax + Zanubrutinib


Bendamustine + Rituximab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | BEL | AUT

No variant requirements are available.